Franz Koenig (F Koenig, Franz König)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Peritoneal Dialysis

Top Venues

Pharmaceutical statistics

Statistics in medicine

Biometrical journal. Biometrische Zeitschrift

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Burnett, Franz Koenig, Thomas F Jaki
Adding experimental treatment arms to multi-arm multi-stage platform trials in progress. Statistics in medicine (2024)
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics 116 (1) (2024)
Thomas Burnett, Franz Koenig, Thomas F Jaki
Adding experimental treatment arms to multi-arm multi-stage platform trials in progress. Statistics in medicine 43 (18) (2024)
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics (2024)
Ullrich Bethe, Zoi Dorothea Pana, Christian Drosten, Herman Goossens, Franz Koenig, Arnaud Marchand, Geert Molenberghs, Martin Posch, Pierre van Damme, Oliver Andreas Cornely
Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paper. Infection (2024)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
David S Robertson, James M S Wason, Franz Koenig, Martin Posch, Thomas F Jaki
Online error rate control for platform trials. Statistics in medicine (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz Koenig, null null
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. PloS one 18 (3) (2023)
Krystell Oviedo Flores, Lukas Kaltenegger, Fabian Eibensteiner, Markus Unterwurzacher, Klaus Kratochwill, Christoph Aufricht, Franz Koenig, Andreas Vychytil
Publisher Correction: Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study. Scientific reports 12 (1) (2022)
Cihan Ay, Katarina D Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Ulrike Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger
von Willebrand Factor-binding aptamer rondoraptivon pegol as treatment for severe and non-severe hemophilia A. Blood (2022)
Krystell Oviedo Flores, Lukas Kaltenegger, Fabian Eibensteiner, Markus Unterwurzacher, Klaus Kratochwill, Christoph Aufricht, Franz Koenig, Andreas Vychytil
Assessing mechanical catheter dysfunction in automated tidal peritoneal dialysis using cycler software: a case control, proof-of-concept study. Scientific reports 12 (1) (2022)
Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf, Ekkehard Glimm, Yuhan Li, Franz Koenig, null null
Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials. Pharmaceutical statistics 21 (3) (2022)
Marta Bofill Roig, Franz Koenig, Elias Meyer, Martin Posch
Commentary: Two approaches to analyze platform trials incorporating non-concurrent controls with a common assumption. Clinical trials (London, England) 19 (5) (2022)
Julia M Neuhann, Jannik Stemler, Antonio J Carcas, Jesús Frías, Ullrich Bethe, Sarah Heringer, Lea Tischmann, Marouan Zarrouk, Arnd Cüppers, Franz Koenig, Martin Posch, Oliver Andreas Cornely
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network. Trials 23 (1) (2022)
Pranab Ghosh, Robin Ristl, Franz Koenig, Martin Posch, Christopher Jennison, Heiko Götte, Armin Schueler, Cyrus R Mehta
Robust group sequential designs for trials with survival endpoints and delayed response. Biometrical journal. Biometrische Zeitschrift 64 (2) (2021)
Nicolás M Ballarini, Thomas Burnett, Thomas F Jaki, Christopher Jennison, Franz Koenig, Martin Posch
Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs. Statistics in medicine 40 (12) (2021)
Elias Laurin Meyer, Peter Mesenbrink, Tobias Mielke, Tom Parke, Daniel Evans, Franz Koenig, null null
Systematic review of available software for multi-arm multi-stage and platform clinical trial design. Trials 22 (1) (2021)
Tanja Eichhorn, Ingrid Linsberger, Lucia Lauková, Carla Tripisciano, Birgit Fendl, René Weiss, Franz Koenig, Gerhard Valicek, Georg Miestinger, Christoph Hörmann, Viktoria Weber
Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors. Mediators of inflammation 2021 (2021)
Nicolás M Ballarini, Yi-Da Chiu, Franz Koenig, Martin Posch, Thomas F Jaki
A critical review of graphics for subgroup analyses in clinical trials. Pharmaceutical statistics 19 (5) (2020)
Robin Ristl, Nicolás M Ballarini, Heiko Götte, Armin Schueler, Martin Posch, Franz Koenig
Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology. Pharmaceutical statistics 20 (1) (2020)
Nigel Stallard, Lisa Hampson, Norbert Benda, Werner Brannath, Thomas Burnett, Tim Friede, Peter K Kimani, Franz Koenig, Johannes Krisam, Pavel Mozgunov, Martin Posch, James M S Wason, Gernot Wassmer, John Whitehead, S Faye Williamson, Sarah Zohar, Thomas F Jaki
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19. Statistics in biopharmaceutical research 12 (4) (2020)
Julia Niewczas, Cornelia U Kunz, Franz Koenig
Interim analysis incorporating short- and long-term binary endpoints. Biometrical journal. Biometrische Zeitschrift 61 (3) (2019)
Silke Jörgens, Gernot Wassmer, Franz Koenig, Martin Posch
Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations. Pharmaceutical statistics 18 (3) (2019)
Marius Thomas, Björn Bornkamp, Martin Posch, Franz Koenig
A multiple comparison procedure for dose-finding trials with subpopulations. Biometrical journal. Biometrische Zeitschrift 62 (1) (2019)
Thomas F Jaki, Allan Gordon, Pamela Forster, Luc Bijnens, Bjoern Bornkamp, Werner Brannath, Roberto Fontana, Mauro Gasparini, Lisa V Hampson, Tom Jacobs, Byron Jones, Xavier Paoletti, Martin Posch, Andrew Titman, Richardus Vonk, Franz Koenig
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873. Pharmaceutical statistics 18 (3) (2019)
Thomas F Jaki, A Gordon, P Forster, L Bijnens, B Bornkamp, Werner Brannath, R Fontana, M Gasparini, L V Hampson, T Jacobs, B Jones, X Paoletti, M Posch, A Titman, R Vonk, Franz Koenig
A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical statistics 17 (5) (2018)
Gerald Hlavin, Lisa V Hampson, Franz Koenig
Many-to-one comparisons after safety selection in multi-arm clinical trials. PloS one 12 (6) (2017)